TickerFacts.

TFA Therapeutics, Inc. (RAJAF): R&D Expense

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest R&D Expense is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$118.4K
Year ended 2022-12-31
2021-12-31: $25.1K2022-12-31: $118.4K$118.4K
2021-12-31 R&D Expense (USD) 2022-12-31
Period endedR&D ExpenseChange YoYSource filing
2022-12-31$118.4K+372.8%2025-09-23, From 2022-01-01
2021-12-31$25.1Kn/a2025-09-23, From 2021-01-01